Tilray Inc (NASDAQ:TLRY – Get Free Report) was up 1.8% on Thursday . The stock traded as high as $1.97 and last traded at $1.96. Approximately 5,823,184 shares changed hands during trading, a decline of 77% from the average daily volume of 25,785,512 shares. The stock had previously closed at $1.92.
Tilray Stock Down 0.5 %
The company has a market cap of $1.64 billion, a P/E ratio of -4.41 and a beta of 2.19. The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10. The company has a fifty day moving average of $1.80 and a 200 day moving average of $1.89.
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings results on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The business had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. Tilray’s revenue for the quarter was up 24.8% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.15) EPS. On average, research analysts anticipate that Tilray Inc will post -0.12 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
- Five stocks we like better than Tilray
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Investing in Construction Stocks
- MarketBeat Week in Review – 8/12 – 8/16
- Using the MarketBeat Stock Split Calculator
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.